TWI263502B - Pharmaceutical preparation for treating ischemic disease of heart or limbs - Google Patents

Pharmaceutical preparation for treating ischemic disease of heart or limbs

Info

Publication number
TWI263502B
TWI263502B TW088113375A TW88113375A TWI263502B TW I263502 B TWI263502 B TW I263502B TW 088113375 A TW088113375 A TW 088113375A TW 88113375 A TW88113375 A TW 88113375A TW I263502 B TWI263502 B TW I263502B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical preparation
limbs
heart
ischemic disease
treating ischemic
Prior art date
Application number
TW088113375A
Other languages
English (en)
Inventor
Tomokazu Nagano
Ikue Kudo
Takao Kawamura
Mutsuo Taiji
Hiroshi Noguchi
Original Assignee
Sumitomo Pharmacueticals Co Lt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmacueticals Co Lt filed Critical Sumitomo Pharmacueticals Co Lt
Application granted granted Critical
Publication of TWI263502B publication Critical patent/TWI263502B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
TW088113375A 1998-08-05 1999-08-05 Pharmaceutical preparation for treating ischemic disease of heart or limbs TWI263502B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22217098 1998-08-05
JP626199 1999-01-13

Publications (1)

Publication Number Publication Date
TWI263502B true TWI263502B (en) 2006-10-11

Family

ID=26340360

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088113375A TWI263502B (en) 1998-08-05 1999-08-05 Pharmaceutical preparation for treating ischemic disease of heart or limbs

Country Status (10)

Country Link
US (1) US6887477B1 (zh)
EP (1) EP1103269B1 (zh)
KR (1) KR100761675B1 (zh)
CN (1) CN1222310C (zh)
AT (1) ATE499946T1 (zh)
AU (1) AU5065599A (zh)
CA (1) CA2339378A1 (zh)
DE (1) DE69943240D1 (zh)
TW (1) TWI263502B (zh)
WO (1) WO2000007615A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022163A1 (fr) * 2000-09-13 2002-03-21 Chugai Seiyaku Kabushiki Kaisha Remedes contre des maladies ischemiques
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
DE602005003211T2 (de) * 2004-03-09 2008-02-21 Tohoku Technoarch Co., Ltd., Sendai Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung
WO2008102452A1 (ja) * 2007-02-22 2008-08-28 Kringle Pharma Inc. Ｈｇｆ製剤
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
CN105682676B (zh) 2013-10-22 2020-10-23 赫利世弥斯株式会社 利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP3283288B2 (ja) 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
WO1993003061A1 (en) * 1991-07-26 1993-02-18 Toray Industries, Incorporated Hematopoietic stem cell multiplier
JP3394982B2 (ja) * 1991-11-07 2003-04-07 敏一 中村 ガン療法用副作用防止剤
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
US6498144B1 (en) * 1993-10-18 2002-12-24 North Shore - Long Island Jewish Research Institute Use of scatter factor to enhance angiogenesis
JP3818322B2 (ja) * 1994-04-28 2006-09-06 敏一 中村 コラーゲン分解促進剤
JP3977452B2 (ja) * 1995-02-27 2007-09-19 敏一 中村 動脈疾患治療剤
AU7254896A (en) * 1995-10-05 1997-04-28 Genentech Inc. Improved angiogenesis using hepatocyte growth factor
CN1250379A (zh) * 1997-01-23 2000-04-12 住友制药株式会社 糖尿病治疗剂
AU6311498A (en) * 1997-03-15 1998-10-12 Sumitomo Pharmaceuticals Company, Limited Hgf for treating acute renal failure

Also Published As

Publication number Publication date
CN1315867A (zh) 2001-10-03
EP1103269B1 (en) 2011-03-02
AU5065599A (en) 2000-02-28
CA2339378A1 (en) 2000-02-17
KR20010072207A (ko) 2001-07-31
ATE499946T1 (de) 2011-03-15
EP1103269A1 (en) 2001-05-30
KR100761675B1 (ko) 2007-10-04
US6887477B1 (en) 2005-05-03
CN1222310C (zh) 2005-10-12
DE69943240D1 (de) 2011-04-14
WO2000007615A1 (fr) 2000-02-17
EP1103269A4 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
BG106171A (en) Compositions and uses of et743 for treating cancer
EP0355811A3 (en) Thrombus control agent
DE19680768D2 (de) Pharmazeutische Kombinationspräparate enthaltend Erythropoietin und Eisenpräparate
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
IL106785A (en) Use of nadh and nadph as drugs for treating alzheimer's disease
GR3032224T3 (en) Therapeutic agent for threatened abortion.
EP0803256A4 (en) MEDICINES FOR RELIEVING SIDE EFFECTS CAUSED BY IMMUNODEPRESSANTS
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
PT1265629E (pt) Utilizacao da hormona de crescimento em dose baixa
Tuck Hypertension in the elderly. Part 1. The case for treatment.
CA2159609A1 (en) Factor xiii for treatment of skin wounds
JPS62242671A (ja) 癌の治療薬
RU2000112472A (ru) Способ ангиографического контрастирования артерий нижних конечностей
IT1236834B (it) Complessi del 4-idrossi-2-metil-n--2-piridinil-2-h,2-benzotiazina-3- carbossiammide-1,1-diossido con cilodestrine, aventi azione anti- infiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees